Inspira Technologies Oxy B.H.N. Ltd. (IINN) has released an update.
Inspira Technologies Oxy B.H.N. Ltd. has initiated a program to advance its INSPIRA ART100 Device as an artificial womb, aiming to provide a safer respiratory support alternative for newborns with critical conditions. The technology could potentially transform neonatal care by replacing traditional mechanical ventilators, which are associated with significant risks and complications. The company’s innovative approach underscores its commitment to enhancing medical treatments for the most vulnerable patients.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
